[
    [
        {
            "time": "",
            "original_text": "[推荐评级]医药生物行业周报：继续推荐龙头公司",
            "features": {
                "keywords": [
                    "医药生物",
                    "周报",
                    "龙头公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[推荐评级]医药生物行业周报：继续推荐龙头公司",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[推荐评级]医药生物行业2018年一季报和2017年业绩回顾：板块增速回升 关注优质白马及高成长个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "2018年一季报",
                    "2017年业绩",
                    "板块增速",
                    "优质白马",
                    "高成长个股"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级]医药生物行业2018年一季报和2017年业绩回顾：板块增速回升 关注优质白马及高成长个股",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[优于大势评级]医药生物行业深度报告：行业持续改善 18Q1迎来小爆发",
            "features": {
                "keywords": [
                    "医药生物",
                    "深度报告",
                    "行业持续改善",
                    "18Q1",
                    "小爆发"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[优于大势评级]医药生物行业深度报告：行业持续改善 18Q1迎来小爆发",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]